162 related articles for article (PubMed ID: 7992071)
1. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
[TBL] [Abstract][Full Text] [Related]
2. The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1989 Aug; 16(4 Suppl 6):116-22. PubMed ID: 2669133
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
Hainsworth JD; Greco FA
Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
[TBL] [Abstract][Full Text] [Related]
4. One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-101-S19-105. PubMed ID: 9427278
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of unknown primary site.
Greco FA; Burris HA; Erland JB; Gray JR; Kalman LA; Schreeder MT; Hainsworth JD
Cancer; 2000 Dec; 89(12):2655-60. PubMed ID: 11135228
[TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated carcinoma and germ cell tumors.
Hainsworth JD; Greco FA
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1223-31. PubMed ID: 1663941
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
Hainsworth JD; Johnson DH; Greco FA
J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
[TBL] [Abstract][Full Text] [Related]
8. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
Greco FA; Johnson DH; Hainsworth JD
Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
[TBL] [Abstract][Full Text] [Related]
9. Managing carcinomas of unknown primary site.
Hainsworth JD; Greco FA
Oncology (Williston Park); 1988 Jul; 2(7):43-9, 52-4. PubMed ID: 3275052
[TBL] [Abstract][Full Text] [Related]
10. Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site.
Hainsworth JD; Dial TW; Greco FA
Am J Clin Oncol; 1988 Apr; 11(2):138-45. PubMed ID: 2451881
[TBL] [Abstract][Full Text] [Related]
11. The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.
Hainsworth JD; Johnson DH; Greco FA
Semin Oncol; 1992 Apr; 19(2 Suppl 5):54-7; discussion 58. PubMed ID: 1384145
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.
Park YH; Ryoo BY; Choi SJ; Yang SH; Kim HT
Jpn J Clin Oncol; 2004 Nov; 34(11):681-5. PubMed ID: 15613558
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac metastasis of poorly differentiated adenocarcinoma of unknown primary site].
Mazzoccoli G; Carughi S; La Viola M; De Cata A; Puzzolante F; Camagna A; Russo A; Caparrotti S
Ital Heart J Suppl; 2002 Nov; 3(11):1112-6. PubMed ID: 12506513
[TBL] [Abstract][Full Text] [Related]
15. [Cytostatic treatment of metastatic adenocarcinoma and anaplastic carcinoma of unknown primary origin].
Aabo K; Rørth M; Hansen HH
Ugeskr Laeger; 1987 Jan; 149(2):80-1. PubMed ID: 3810973
[No Abstract] [Full Text] [Related]
16. Multiple nodules on the face and trunk in metastatic adenocarcinoma of unknown primary origin.
Furtado S; Bhat RM; Sukumar D; Krishnamurthy SG; Rao SD; Nandakishore B
Singapore Med J; 2011 Jul; 52(7):e163-6. PubMed ID: 21808952
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203
[TBL] [Abstract][Full Text] [Related]
18. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
19. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine carcinoma of unknown primary site.
Spigel DR; Hainsworth JD; Greco FA
Semin Oncol; 2009 Feb; 36(1):52-9. PubMed ID: 19179188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
